School of Medicine

Showing 31-40 of 40 Results

  • Aimee D. Shu

    Aimee D. Shu

    Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Bio I am an endocrinologist with particular interests in reproductive and bone health.

    I enjoy treating patients with menstrual disorders, menopause, fractures, osteoporosis, parathyroid imbalance, and calcium imbalance.

    As a certified menopause practitioner (North American Menopause Society), I help women fine-tune their health at the mid-life transition. Some women transition through menopause with ease, while others experience challenging symptoms like hot flashes, slowed metabolism, and mood changes. This transition period provides a good opportunity to create a "game plan" for preserving future health. It also marks the beginning of natural bone loss, leaving one more susceptible to fragility fractures.

    I provide individualized treatment plans for bone health to men and women of all ages, including for those with specific challenges such as chronic steroid use. As a certified clinical densitometrist (International Society for Clinical Densitometry), I personally review all my patients' bone density scan images. Thus, please bring any non-Stanford bone density scan images to your appointment with me.

    Appointments with me are available on Stanford's main campus (300 Pastuer Drive) and at the Stanford Medicine Outpatient Center (450 Broadway, Redwood City).

  • Marilyn Tan

    Marilyn Tan

    Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

    Current Research and Scholarly Interests Type 2 diabetes, obesity, insulin resistance

  • Jason Wong

    Jason Wong

    Postdoctoral Research fellow, Endocrinology, Gerontology, and Metabolism

    Bio I am a graduate of the Harvard School of Public Health with a dual-doctorate in molecular / genetic epidemiology and environmental health. During my doctoral training, I developed extensive skills in quantitative analysis, epidemiological study design, and causal inference in observational studies. However, I am best described as a genomic trauma specialist focusing on the relationship between molecular markers, telomere dynamics, and risk of chronic diseases.

    My career in biological research began at the British Columbia Cancer Agency under the guidance of Dr. Keith Humphries, a world renowned expert on the genetics of hematological disorders. It was in the Humphrie’s laboratory that I developed a strong foundation in molecular genetic techniques which served as a primer for the rest of my career. Subsequently, I became research laboratory manager for Dr. Immaculata De Vivo, a pioneer in molecular epidemiology at the Channing Division of Network Medicine at the Brigham and Women’s Hospital. Not only did I hone my expertise in molecular biology, but also received extensive training in the burgeoning field of molecular and genetic epidemiology. I used a three-pronged paradigm in my research to combat cancer; understanding genetic and biological susceptibility, prevention by attenuating modifiable risk factors, and treatment of underlying causative factors. With respect to genetic susceptibility, my projects focused on functional characterization of polymorphisms which predisposed women to endometrial cancer. With respect to attenuating modifiable risk factors, we studied how smoking and other lifestyle choices affect cancer risk. With respect to treatment of underlying disease, I studied how a novel therapeutic molecule called dichloroacetate induces cell death in a panel of endometrial cancer cells.

    My doctoral thesis focused on the effect of airborne particulate matter on telomere length, mediated through chronic inflammation and global DNA methylation. Furthermore, I investigated gene-environment interactions with respect to endometrial cancer risk in the Nurses Health Study. My interest in predictors of chronic disease is not limited to only biological and environmental factors, but also social factors such as exposure to racism and early-life adversity in susceptible populations.

  • Joy Wu

    Joy Wu

    Assistant Professor of Medicine (Endocrinology)

    Current Research and Scholarly Interests My laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic stem cell niche and B lymphocyte development in the bone marrow microenvironment.

Stanford Medicine Resources: